Physician profile
Patrick A Eigbe
NPI 1457701856
$1,033.13
in general payments reported to CMS, 2019-2025
12 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $21.79 · 2021: $250 · 2022: $99.20 · 2024: $145 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $271.79 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $124.91 | 2021 | |
| Novo Nordisk INC | $103.60 | 2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company Ltd. | $99.20 | 2022 | |
| Lilly USA, LLC | $93.76 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $86.91 | 2024-2025 | Gardasil 9, Capvaxive, Proquad |
| Exact Sciences Corporation | $86.00 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $53.37 | 2024-2025 | |
| Cequr Corporation | $46.46 | 2024-2025 | Cequr Simplicity |
| Alkermes, INC. | $31.46 | 2025 | Vivitrol |
| Abbott Laboratories | $18.92 | 2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $16.75 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Eigbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.